focus -WSS

focus

author：hotspot 2025-10-01 06:01:45 - browse：63

Illustration of a dollar sign with arrows. — Adobe

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

Centene, for instance, says, it is “investing in artificial intelligence and machine learning technologies to improve the health of our members and contain rising healthcare costs.” The insurer, whose plans cover more than 28 million Americans, noted that its large footprint, particularly in government-sponsored programs, puts it “in a unique position to use data to develop models that predict a wide range of health outcomes.”

A STAT review of regulatory filings from publicly traded health insurers showed that several of them, including Elevance, Molina, and Cigna, are investing in AI with the goal of saving money. Elevance has hired nearly 500 people to work exclusively on AI. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

explore

WSS

FDA has safety concerns on CRISPR

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Churchill Downs extends trainer Bob Baffert's ban through 2024

FDA has safety concerns on CRISPR

A timeline of the missing Titanic tourist submersible

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Sports medicine is finally prioritizing gender equality

Readout Newsletter: XBI biotech index, Akero Therapeutics

Guidelines to prevent youth baseball injuries need more muscle

Trump pressured former Arizona governor to overturn 2020 election results: Sources

After affirmative action ruling, medical educators look to 'holistic review'

Meta's Zuckerberg and Chan on track to put $50 billion into science

Virginia high school admissions case could be legal follow

Telehealth options flood the market as retailers push virtual care

Jerome Adams on the need for new antivirals for Covid

Churchill Downs extends trainer Bob Baffert's ban through 2024

explore

Leon Gautier, last member of French D

A timeline of the missing Titanic tourist submersible

Eli Lilly to pay $200M for Beam’s stake in gene

Meta's Zuckerberg and Chan on track to put $50 billion into science

Medtronic CEO on promising devices for diabetes, hypertension

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

entertainment

explore

entertainment

leisure time